Suicidal risks during treatment of bipolar disorder patients with lithium versus anticonvulsants

Pharmacopsychiatry

Volumn 42, Issue 2, 2009, Pages 72-75

  Baldessarini, R J ^a,b   Tondo, L ^a,b,c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d Lucio Bini Mood Disorder Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; VALPROATE SEMISODIUM; ANTICONVULSIVE AGENT; LITHIUM DERIVATIVE;

ARTICLE; BIPOLAR DISORDER; HUMAN; LONG TERM CARE; PRIORITY JOURNAL; RISK ASSESSMENT; SUICIDE; SUICIDE ATTEMPT; COMPARATIVE STUDY; LETTER; META ANALYSIS; PSYCHOLOGICAL ASPECT; RISK; STATISTICS; TREATMENT OUTCOME;

ANTICONVULSANTS; BIPOLAR DISORDER; HUMANS; LITHIUM COMPOUNDS; ODDS RATIO; SUICIDE; TREATMENT OUTCOME;

EID: 67649229667     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0028-1103291     Document Type: Article

References (21)

1. Ahrens B, Muller-Oerlinghausen B. Does lithium exert and independent antisucidal effect? Pharmacopsychiatry 2001 ; 34 : 132-136
2. Baldessarini RJ, Tarazi FI. Pharmacotherapy of psychiatric disorders Chapters 17 and 18 in: Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 11th edition. McGraw-Hill Press, New York ; 2005 ; 429-500
3. Baldessarini RJ, Tondo L. Lithium and suicidal risk. Bipolar Disord 2008 ; 10 : 114-115
4. Baldessarini RJ, Tondo L, Davis P et al. Decreased risk of suicides and attempts during long-term lithium treatment: meta-analytic review. Bipolar Disord 2006 ; 8 : 625-639
5. Baldessarini RJ, Tondo L, Hennen J. Antisuicidal effects of lithium in manic-depressive disorders. J Clin Psychiatry 1999 ; 60 (Suppl. 2) : 77-84
6. Bowden CL, Calabrese JR, Sachs G et al. Lamictal 606 Study Group. Placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003 ; 60 : 392-400 (Pubitemid 36403000)
7. Calabrese JR, Bowden CL, Sachs G et al. Lamictal 605 Study Group. Placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder . J Clin Psychiatry 2003 ; 64 : 1013-1024 (Pubitemid 37158246)
8. Collins JC, MacFarland BH. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J Affect Disord 2008 ; 107 : 23-28
9. Goodwin FK, Fireman B, Simon GE et al. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003 ; 290 : 1467-1473
10. Greil W, Ludwig-Mayerhofer W, Erazo N et al. Lithium vs. carbamazepine in the maintenance treatment of bipolar disorders: randomized study. J Affect Disord 1997 ; 43 : 151-161 (Pubitemid 27219568)
11. Kallner G Lindelius E, Petterson U, Stockman O et al. Mortality in 497 patients with affective disorders attending a lithium clinic or after having left. Pharmacopsychiatry 2000 ; 33 : 8-13
12. Kessing LV, Sønderg ård L, Kvist K et al. Suicide risk in patients treated with lithium. Arch Gen Psychiatry 2005 ; 62 : 860-866
13. Meltzer HY, Alphs L, Green AI et al. International suicide prevention trial study group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003 ; 60 : 82-91
14. Müller-Oerlinghausen B. Pharmacological suicide prevention under special consideration of lithium salts. Psychiatr Prax 2007 ; 34 (Suppl. 3) : S292-S295
15. Simhandl C, Mersch J. Lithium and bipolar disorder - a renaissance? Neuropsychiatrie 2007 ; 21 : 121-130
16. Tondo L, Baldessarini RJ. Risks of suicidal ideation, attempts and suicides among 2 826 men and women with types I and II bipolar, and recurrent major depressive disorders. Acta Psychiatr Scand 2007 ; 116 : 419-428
17. Tondo L, Baldessarini RJ, Hennen J et al. Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry 1998 ; 59 : 405-414
18. Tondo L, Isacsson G, Baldessarini RJ. Suicide in bipolar disorder: Risk and prevention. CNS Drugs 2003 ; 17 : 491-511
19. US Food and Drug Administration (FDA). Antiepileptic drugs statistical review and evaluation: Antiepileptic Drugs AEDs) and Suicidality Accessed at: http.www.fda.gov/ohrms/dockets/ac/08/ briefi ng/2008- 4372b1-01-FDA.pdf on 20 August, 2008
20. Yerevanian BI, Koeka RJ, Mintz J. Lithium, ACs and suicidal behavior in bipolar disorder. J Affect Disord 2003 ; 73 : 223-228
21. Yerevanian BI, Koek RJ, Mintz J. Bipolar pharmacotherapy and suicidal behavior: lithium, divalproex, and carbamazepine. J Affect Disord 2007 ; 103 : 5-11 (Pubitemid 47445781)